Given the high expression of SLC6A20 gene in a variety of human cancers, the UALCAN database was utilized.Expression of SCL6A20 was found to be statisticallyhigher in stage 1-to-4 in COAD and READ samples compared to normalsamples (Figure 3A,B).In KIRP, SCL6A20 expression was found to be higheronly in stage 1 and stage 4 samples in comparison to normal samples,while the mRNA expression of SCL6A20 in stage 2 andstage 3 samples was not significantly upregulated (Figure 3C). This evidence concerns the gene SLC6A20 and cancer.